Posts

COPD - Twitter summary from #ACAAI18 meeting

COPD, ACO and the Chronic Airflow Obstruction Phenotype - 2018 WSAAI update

Early-Life Origins of COPD

Tiotropium (LAMA) step-up therapy for asthma uncontrolled with ICS works as well as adding LABA

Asthma in the elderly - differences in diagnosis and management

Children with severe asthma are at high risk of developing COPD

Stedivaze (apadenoson) - A2A receptor agonist in trials as stress agent for patients with asthma and COPD

Replacing the terms asthma and COPD with "A to E" of airway disease?

Inhaled steroids decrease inflammation in COPD but adding LABAs may not enhance these effects

Tc1 cells have a detrimental role and Tc2 cells have a protective role in COPD disease progression

LABA plus LAMA combination products for COPD and asthma

Advantages of indacaterol, once-daily ultra long-acting beta2-agonist for asthma and COPD

25–45% of patients with COPD have never smoked

Phosphodiesterase-4 inhibition for treatment of COPD: Roflumilast

Diagnosis and prognosis of COPD

5 inflammation-sensitive plasma proteins associated with an increased incidence of COPD hospitalizations

Occupational exposures (smoking + VGDF) increase risk of COPD

Inhaled steroids may increase pneumonia risk in COPD